Table 1.
Sociodemographic characteristics of participants at baseline (N = 370).
| Mean (SD) N (%) | Skewness/Kurtosis | |
|---|---|---|
| Age | 44.79 (7.3) | −0.56/−0.13 |
| Gender (male) | 233 (63.5) | −0.56/−0.69 |
| Hispanic ethnicity (yes) | 53 (15) | 1.97/1.90 |
| Race | ||
| Black | 266 (76.2) | −1.24/−0.47 |
| White | 50 (14.3) | 2.05/2.20 |
| Years education | 0.41/−0.17 | |
| <HS diploma | 157 (44.3) | – |
| ≥HS diploma | 198 (55.7) | – |
| Employed (Yes) | 29 (8.2) | 3.07/7.45 |
| Years since HIV diagnosis | 12.15 (7.5) | 0.20/−1.01 |
| Time from HIV diagnosis to treatment | 0.65/−1.41 | |
| Within 6 weeks | 206 (58.4) | – |
| 6–12 weeks | 13 (3.7) | – |
| 3–6 months | 22 (6.2) | – |
| 6 months–1 year | 25 (7.1) | – |
| 1 year+ | 87 (24.6) | – |
| Taking ART (yes) | 273 (76.7) | −1.27/−0.40 |
| Currently in residential substance treatment | 84 (23.5) | 0.66/−1.27 |
| Days using in last 3 months | ||
| Alcohol | 15.77 (23.33) | 1.86/2.83 |
| Marijuana | 9.29 (20.68) | 2.84/7.59 |
| Cocaine | 15.68 (23.89) | 1.89/2.80 |
| Neurocognitive functioning | ||
| CTT2 | 116.31 (49.82)a | 1.71/4.97 |
| SCT | 38.09 (15.58)a | −0.38/−0.86 |
| AVLT | 43.44 (9.63)a | −0.03/−0.22 |
aRaw scores reported. All sample means are significantly different from normative sample at p < 0.01.
Normative scores used for comparison testing represented mean age and education for this sample. Skewness and Kurtosis values for neurocognitive instruments reflect distribution of scores prior to square root transformation.